IM
Immunocore
IMCR·NASDAQAbingdon UKFounded 2008700 employees
Mid CapbiotechPublicOncology
Platform: ImmTAX
Market Cap
$3.5B
All Drugs
3
Clinical Trials
8
Failed / Terminated
3
FDA Approved
1
Stock Price & Catalysts (IMCR)
Loading IMCR stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Olpafutibatinib | IMC-6193 | Approved | 4 | SMN2 | NMOSDMigraine | ||
| Zanurapivir | IMC-3738 | Phase 1 | 2 | SOS1 | MesoThymoma | ||
| Terainavolisib | IMC-6589 | Preclinical | 2 | FXIa | ALLCF |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (8)